FOXP2-related speech and language disorder
Learn about FOXP2-related speech and language disorder, its reported features, relevant specialists, and questions to discuss at a medical consultation.
Also known as: Speech and language disorder with orofacial dyspraxia; Speech-language disorder 1
The sources compiled here do not cover: diagnosis, prevention. Ask the treating doctor about these.
What it is, symptoms and effects
From: MedlinePlus Genetics, National Library of Medicine
FOXP2-related speech and language disorder affects the development of speech and language beginning in early childhood. Affected individuals have a condition known as childhood apraxia of speech (CAS), which makes it difficult to produce the sequences of sounds and syllables needed to form words. CAS is caused by abnormalities in the parts of the brain that plan and coordinate the movements of the lips, mouth, and tongue. Children with FOXP2-related speech and language disorder say their first words later than other children, typically between 18 months and 7 years of age. Their speech is often difficult to understand, although the clarity of speech usually improves over time.
In addition to having problems with producing speech (expressive language), people with FOXP2-related speech and language disorder may have difficulty understanding speech (receptive language). Some affected individuals also have trouble with other language-related skills, such as reading, spelling, and grammar.
Less commonly, individuals with FOXP2-related speech and language disorder have features of autism spectrum disorder, which is a condition characterized by impaired social skills and communication problems. Some affected individuals have difficulty with motor skills such as walking, writing, or buttoning clothes, but these typically improve with treatment. Some affected individuals may have learning difficulties.
Causes and biological mechanisms
From: MedlinePlus Genetics, National Library of Medicine
Variants (also called mutations) in the FOXP2 gene cause FOXP2-related speech and language disorder. The FOXP2 gene provides instructions for making a protein that acts as a transcription factor, which means that it controls the activity of other genes. Researchers suspect that this protein plays an important role in the functioning of synapses, which are the connections between nerve cells (neurons) where cell-to-cell communication occurs.
In people with FOXP2-related speech and language disorder, variants in the FOXP2 gene cause cells to produce an abnormal version of the FOXP2 protein that does not function properly. Because the FOXP2 protein is a transcription factor, changes in the protein's activity affect the activity of other genes in the developing brain. Researchers suspect that many of the genes targeted by the FOXP2 protein play important roles in brain development and the connections between neurons.
The FOXP2 gene is one of the genes found on chromosome 7. When large deletions or rearrangements of genetic material on this chromosome affect the FOXP2 gene and neighboring genes, it can cause a disorder known as FOXP2-plus-related speech and language disorder. Because other genes are involved, individuals with FOXP2-plus-related speech and language disorder are more likely to have features such as developmental delays and autism spectrum disorder than individuals who only have a variant in the FOXP2 gene.
Inheritance and family implications
From: MedlinePlus Genetics, National Library of Medicine
FOXP2-related speech and language disorder is inherited in an autosomal dominant pattern, which means one copy of the altered gene in each cell is sufficient to cause the disorder. In approximately 50 percent of cases, the condition results from a new (de novo) variant in the gene that occurs during the formation of reproductive cells (eggs or sperm) in an affected individual's parent or during early embryonic development. These affected individuals typically have no history of the disorder in their family.
The inheritance of FOXP2-plus-related speech and language disorder is more complex and depends on the specific genetic change.
How common is it?
From: MedlinePlus Genetics, National Library of Medicine
FOXP2-related speech and language disorder is a rare disorder, although its exact prevalence is unknown. CAS affects approximately 1 to 2 in 1,000 people, but it is thought that FOXP2-related speech and language disorder accounts for only a small portion of these cases.
Which doctor should you see?
The suggested department for discussing FOXP2-related speech and language disorder is Clinical Genetics, with a clinical geneticist as the relevant type of clinician. Paediatrician (children) or physician (adults), with clinical geneticist referral.
This is an editorial referral starting point. The appropriate clinic depends on the person’s age, symptoms, previous diagnosis and local services. The first clinician can decide whether another specialty or a team is needed; a department label does not confirm the diagnosis.
How to prepare for an assessment
Bring a short timeline of the main symptoms: when they first appeared, whether they are constant or episodic, what seems to change them, and how they affect daily activities. Include previous reports, discharge summaries, current medicines and supplements, allergies, and any relevant family history. A dated record is more useful than trying to match every feature in an online article.
Ask the clinician what is already established and what remains uncertain. If a test is suggested, ask what question it answers, what its limitations are and how the result would change the next step. The information here is not an instruction to arrange every possible test. In children, bring growth, developmental and school information if it is relevant to the concern.
- Does the exact genetic or chromosome finding explain the observed features?
- Would a genetic counsellor help the family understand the result?
- Which organ-specific assessments are appropriate for this particular diagnosis?
Treatment discussions and follow-up
Where the source describes treatments, these are an overview of possible care, not a prescription for an individual. Ask which option applies to the confirmed diagnosis, what benefit is expected, what adverse effects to watch for and how progress will be assessed. Availability, approvals and local practice can differ from the country described in the source.
Before leaving the appointment, clarify the next review date, who will communicate results, and whom to contact if the situation changes. Discuss difficulties with sleep, work, school, mobility, eating or emotional wellbeing when these are relevant. Practical support may require coordination between the treating clinician and other services.
The collected references do not establish a complete prevention or long-term outlook section for this entry. Missing information should not be interpreted as proof that prevention is impossible or that a particular outcome is inevitable. Ask what is known for the exact subtype, stage and personal circumstances, and which uncertainties remain.
When to seek emergency help
Severe breathing difficulty, collapse, new stroke-like symptoms, a seizure that is prolonged or repeated without recovery, uncontrolled major bleeding, or an immediate risk of self-harm require emergency help. In India, call 112 or reach the nearest emergency department. This is a general, non-exhaustive warning list; it is not a condition-specific triage tool.
This condition is usually assessed by a clinical geneticist. The Doctor Index does not list that speciality yet. A family physician or paediatrician can examine, arrange first tests and refer to the right specialist centre.
All clinical genetics conditions →
Sources
- MedlinePlus Genetics, National Library of Medicine — FOXP2-related speech and language disorder — Public-domain Genetics summary
- Government of India — Emergency Response Support System — Official reference for India emergency number
Source: MedlinePlus, National Library of Medicine. Orphadata Science: Free access data from Orphanet. © INSERM 1999; July 2026 data, CC BY 4.0. This product uses the Human Phenotype Ontology (hp/releases/2026-09-01). Only sources listed for this article apply. Source material has been selected and arranged; HPO definitions are reproduced without alteration. No source organisation endorses this compilation. Köhler S et al. The Human Phenotype Ontology project: linking molecular biology and disease through phenotype data. Nucleic Acids Research 2014;42(D1):D966–D974. doi:10.1093/nar/gkt1026.
General information, not advice about your situation. Errors can be reported through the corrections process. Reference TDI-C-0949.